Erratum: Vol. 53, No. RR-14

In the MMWR Recommendations and Reports, "Treating Opportunistic Infections Among HIV-Exposed and Infected Children: Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America," in Appendix A, on page 65, an incorrect dosage was provided for infants and children with Pneumocystis jiroveci pneumonia under the column heading, "Preferred therapies and duration." The correct dosage is highlighted: "Trimethoprim-sulfamethoxazole (TMP/SMX) 15--20 mg/kg body weight TMP plus 75--100 mg/kg body weight SMX administered intravenously or by mouth in 3--4 divided doses daily (AI) (after acute pneumonitis resolved in mild-moderate disease, intravenous TMP/SMX may be changed to oral)."

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services. References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

Disclaimer   All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to [email protected].

Date last reviewed: 8/3/2006